FDA Center for Biologics Evaluation and Research</a> to monitor and evaluate the safety and effectiveness of various vaccines, blood products, and other biologics. For this important public health collaboration, IQVIA worked with the Observational Health Data Science and Informatics initiative and its world-class team of healthcare experts and unique data assets from Columbia University, Stanford University, Georgia Institute of Technology, University of California, Los Angeles and the Regenstrief Institute at the Indiana University School of Medicine to enhance the function and outputs of the initiative.</p> <p><strong>Fighting the Opioid Epidemic:</strong>&nbsp;IQVIA partnered with the&nbsp;<a rel="noopener noreferrer" href=https://www.iqvia.com/about-us/commitment-to-public-health/"https://www.ama-assn.org/sites/default/files/media-browser/public/physicians/patient-care/opioid-task-force-progress-report.pdf" data-gc-link="https://www.ama-assn.org/sites/default/files/media-browser/public/physicians/patient-care/opioid-task-force-progress-report.pdf" target="_blank">American Medical Association&rsquo;s Task Force to Reduce Opioid Abuse</a>&nbsp;to help reverse the nation&rsquo;s opioid epidemic and provided valuable insight into the ongoing efforts to combat this public health crisis. Our data and analyses helped illustrate the effects of legislation regarding opioids.</p> <p><strong>Bridging Oncology Gaps:&nbsp;</strong><span>IQVIA has established the Cancer Data Network&nbsp;&ndash; a network that reveals insights that can help our oncology community improve cancer care and patient outcomes, accelerate clinical research and enable innovative contracting. IQVIA is a founding member of <a rel="noopener noreferrer" href=https://www.iqvia.com/about-us/commitment-to-public-health/"https://www.data-can.org.uk/" target="_blank">DATA-CAN</a>, the UK&rsquo;s National Health Data Research Hub, and committed to developing the Cancer Data Network as part of the initiative.</span></p> <p><strong>Addressing Antibiotic Resistance:</strong>&nbsp;IQVIA collaborated with&nbsp;<a rel="noopener noreferrer" href=https://www.iqvia.com/about-us/commitment-to-public-health/"https://www.businesswire.com/news/home/20150602006417/en/IMS-Health-Data-Analytics-Drive-White-House" data-gc-link="https://www.businesswire.com/news/home/20150602006417/en/IMS-Health-Data-Analytics-Drive-White-House" target="_blank">the U.S. Centers for Disease Control and Prevention</a>&nbsp;and supported White House efforts to combat the overuse and misuse of antibiotics. Information and analysis identified significant regional and local variability in antibiotic use across the United States. The findings shed light on the driving factors behind the rising number of drug-resistant bacteria strains to better inform ongoing prevention efforts.</p> <p><strong>Assessing Disease Burden, Enabling Innovation:</strong>&nbsp;Tuberculosis is a major global public health challenge and India accounts for more than a quarter of these cases on an annual basis. As part of an effort funded by the Bill and Melinda Gates Foundation,<a rel="noopener noreferrer" href=https://www.iqvia.com/about-us/commitment-to-public-health/"http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(16)30259-6/abstract" data-gc-link="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(16)30259-6/abstract" target="_blank">&nbsp;IQVIA provided crucial information</a>&nbsp;about tuberculosis managed by the private sector to enable understanding of the true disease burden in the country, and around the world. The work revealed significantly higher rates of tuberculosis than had been previously recognized, as well as prospective causes, which can inform preventative protocols going forward.</p> <p><strong>Malaria Access in Action:</strong>&nbsp;Most malaria-endemic countries lack the ability to monitor the relationship between disease burden and the national supply and quality of critically needed medicines. To address this challenge, we collaborated with the&nbsp;<a rel="noopener noreferrer" href=https://www.iqvia.com/about-us/commitment-to-public-health/"https://www.mmv.org/access/products-projects/measuring-pharmaceutical-markets-africa" data-gc-link="https://www.mmv.org/access/products-projects/measuring-pharmaceutical-markets-africa" target="_blank">Medicines for Malaria</a>&nbsp;Venture to consolidate data flow and enable the Uganda National Drug Authority to complete the development of a system for monitoring pharmaceutical use at a national level.</p> <p><strong>Enabling Alzheimer&rsquo;s Insights:</strong>&nbsp;<a rel="noopener noreferrer" href=https://www.iqvia.com/about-us/commitment-to-public-health/"http://ep-ad.org/" data-gc-link="http://ep-ad.org/" target="_blank">European Prevention of Alzheimer's Dementia (EPAD)</a>&nbsp;is a public-private consortium designed to better understand the early stages of Alzheimer&rsquo;s disease and prevent dementia before symptoms occur. EPAD selected IQVIA to oversee a longitudinal study of 6,000 non-identified patients that enables researchers to track development of Alzheimer&rsquo;s disease symptoms.</p>" /> FDA Center for Biologics Evaluation and Research</a> to monitor and evaluate the safety and effectiveness of various vaccines, blood products, and other biologics. For this important public health collaboration, IQVIA worked with the Observational Health Data Science and Informatics initiative and its world-class team of healthcare experts and unique data assets from Columbia University, Stanford University, Georgia Institute of Technology, University of California, Los Angeles and the Regenstrief Institute at the Indiana University School of Medicine to enhance the function and outputs of the initiative.</p> <p><strong>Fighting the Opioid Epidemic:</strong>&nbsp;IQVIA partnered with the&nbsp;<a rel="noopener noreferrer" href=https://www.iqvia.com/about-us/commitment-to-public-health/"https://www.ama-assn.org/sites/default/files/media-browser/public/physicians/patient-care/opioid-task-force-progress-report.pdf" data-gc-link="https://www.ama-assn.org/sites/default/files/media-browser/public/physicians/patient-care/opioid-task-force-progress-report.pdf" target="_blank">American Medical Association&rsquo;s Task Force to Reduce Opioid Abuse</a>&nbsp;to help reverse the nation&rsquo;s opioid epidemic and provided valuable insight into the ongoing efforts to combat this public health crisis. Our data and analyses helped illustrate the effects of legislation regarding opioids.</p> <p><strong>Bridging Oncology Gaps:&nbsp;</strong><span>IQVIA has established the Cancer Data Network&nbsp;&ndash; a network that reveals insights that can help our oncology community improve cancer care and patient outcomes, accelerate clinical research and enable innovative contracting. IQVIA is a founding member of <a rel="noopener noreferrer" href=https://www.iqvia.com/about-us/commitment-to-public-health/"https://www.data-can.org.uk/" target="_blank">DATA-CAN</a>, the UK&rsquo;s National Health Data Research Hub, and committed to developing the Cancer Data Network as part of the initiative.</span></p> <p><strong>Addressing Antibiotic Resistance:</strong>&nbsp;IQVIA collaborated with&nbsp;<a rel="noopener noreferrer" href=https://www.iqvia.com/about-us/commitment-to-public-health/"https://www.businesswire.com/news/home/20150602006417/en/IMS-Health-Data-Analytics-Drive-White-House" data-gc-link="https://www.businesswire.com/news/home/20150602006417/en/IMS-Health-Data-Analytics-Drive-White-House" target="_blank">the U.S. Centers for Disease Control and Prevention</a>&nbsp;and supported White House efforts to combat the overuse and misuse of antibiotics. Information and analysis identified significant regional and local variability in antibiotic use across the United States. The findings shed light on the driving factors behind the rising number of drug-resistant bacteria strains to better inform ongoing prevention efforts.</p> <p><strong>Assessing Disease Burden, Enabling Innovation:</strong>&nbsp;Tuberculosis is a major global public health challenge and India accounts for more than a quarter of these cases on an annual basis. As part of an effort funded by the Bill and Melinda Gates Foundation,<a rel="noopener noreferrer" href=https://www.iqvia.com/about-us/commitment-to-public-health/"http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(16)30259-6/abstract" data-gc-link="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(16)30259-6/abstract" target="_blank">&nbsp;IQVIA provided crucial information</a>&nbsp;about tuberculosis managed by the private sector to enable understanding of the true disease burden in the country, and around the world. The work revealed significantly higher rates of tuberculosis than had been previously recognized, as well as prospective causes, which can inform preventative protocols going forward.</p> <p><strong>Malaria Access in Action:</strong>&nbsp;Most malaria-endemic countries lack the ability to monitor the relationship between disease burden and the national supply and quality of critically needed medicines. To address this challenge, we collaborated with the&nbsp;<a rel="noopener noreferrer" href=https://www.iqvia.com/about-us/commitment-to-public-health/"https://www.mmv.org/access/products-projects/measuring-pharmaceutical-markets-africa" data-gc-link="https://www.mmv.org/access/products-projects/measuring-pharmaceutical-markets-africa" target="_blank">Medicines for Malaria</a>&nbsp;Venture to consolidate data flow and enable the Uganda National Drug Authority to complete the development of a system for monitoring pharmaceutical use at a national level.</p> <p><strong>Enabling Alzheimer&rsquo;s Insights:</strong>&nbsp;<a rel="noopener noreferrer" href=https://www.iqvia.com/about-us/commitment-to-public-health/"http://ep-ad.org/" data-gc-link="http://ep-ad.org/" target="_blank">European Prevention of Alzheimer's Dementia (EPAD)</a>&nbsp;is a public-private consortium designed to better understand the early stages of Alzheimer&rsquo;s disease and prevent dementia before symptoms occur. EPAD selected IQVIA to oversee a longitudinal study of 6,000 non-identified patients that enables researchers to track development of Alzheimer&rsquo;s disease symptoms.</p>" />
Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2024

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience Solutions with Apple devices
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions with Apple devices

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
Commitment to Public Health

Accelerating Global Public Health

Reducing health inequities and driving sustainable change through innovation, collaboration and data-driven solutions.

About Us Commitment to Public Health
Explore More

Global Public Health is at a critical inflection point, where opportunities and possibilities are greater than ever before. We have made great progress over the last decade to advance human health, but these advances still do not consistently reach the people who need them most and complex issues must be addressed.


At IQVIA, our mission is to accelerate the huge potential that can be achieved from reducing health inequities so that everyone can live longer, healthier lives. We believe in the power of scaling up innovation and working in collaboration across sectors to build more resilient, inclusive and sustainable healthcare systems.


Through our local geographical footprint and deep expertise in healthcare systems of the communities in which we serve, the IQVIA Global Public Health team is committed to unlocking extensive capabilities in clinical research, data, analytics, and technology to address complex issues and drive sustainable change through collaboration across a diverse healthcare ecosystem.


We work to bring innovative solutions and connected intelligence to the people who need it most.

Making an Impact Through Collaboration

Through collaboration, IQVIA hope to overcome some of the biggest challenges facing global public health. To support this, IQVIA has partnered with The Global Fund and (RED) supporting initiatives to strengthen healthcare across low- and middle-income countries, including in Africa. Innovative initiatives, such as the Data Science Catalytic Fund, implemented by The Global Fund in collaboration with the Rwandan government, will support technological advances and innovation in local healthcare systems, paving the way for transformative advances in patient care. This initiative will help with the crucial, rapid detection and response to disease outbreaks. We are committed to doing our part by harnessing our resources and expertise to identify, understand, and address unmet public health needs. Watch this video to learn more.

Collaborate

We build local collaborations by bringing together governments, international organizations, business leaders, advocacy groups, and academia to drive better healthcare outcomes for patients and communities globally.

Innovate

Using our global footprint and breadth of expertise across the healthcare continuum, we apply connected intelligence to provide creative, differentiated and bespoke solutions that meet local requirements.

Deliver

Our experience navigating diverse, local landscapes enables us to understand, and meet the needs, of patients and communities better and faster. Through our local footprint and the breadth and depth of our services and capabilities, we are able to address some of global public health’s most pressing challenges.

News

Press Release
IQVIA and CEPI Collaborate to Strengthen Global Research Preparedness to Advance the 100 Days Mission
Press Release
IQVIA & (RED) Announce Groundbreaking Partnership to Support Laboratory System Strengthening

Thought Leadership

Blog
"We are willing and able to make a great difference in global public health."

An interview with David Franks, IQVIA’s Vice President for Global Public Health
BLOG
Reflecting on the value of collaborative surveillance

Conversations with key partners during the 2024 World Economic Forum’s Annual Meeting in Davos
blog
Antimicrobial Resistance: Understanding the Threat and Shaping the Response

BROCHURE
IQVIA Africa Health Summit

Shared value convening and springboard platform to advance Africa’s health through data, technology and innovation
BROCHURE
Africa Health Summit 2022 - Day 1

BROCHURE
Africa Health Summit 2022 - Day 2

WHITE PAPER
Climbing the Mountain One Step at a Time

How patient organizations in Africa are advancing healthcare
WHITE PAPER
Race for Immunity: Exploring the Evolving Landscape of the Vaccines Market

A forward-looking perspective on vaccine innovation
WHITE PAPER
Addressing pharma's carbon footprint

Remedy of the Commons
INSTITUTE REPORT
Scaling-Up Inclusive Healthcare Initiatives in Low- and Middle-Income Countries

Assessing the landscape of innovative approaches
INSTITUTE REPORT
Scaling-up Inclusive Healthcare in Low- and Middle-Income Countries 2

WHITE PAPER
Digital Health Systems in Africa

A convergence of opportunities

Prev
Next
White Paper
Catalyzing Sustainable Funding for Rare Diseases
Blog
Domestic Manufacturing in LMICs Part 3: Five Guiding Principles for Global Health Success
By: Steven Harsono, Siti Nadiah Rusli
Blog
Domestic Manufacturing in LMICs Part 2: Building Supply Chain Resilience
By: Steven Harsono, Siti Nadiah Rusli
Blog
Domestic Manufacturing in LMICs Part 1: Lessons Learned with COVID-19
By: Steven Harsono, Siti Nadiah Rusli
Fact Sheet
IQVIA: The Human Data Science Partner in Public Health Solutions
Fact Sheet
Unlock Patient-Level Social Determinants Of Health With IQVIA NLP

Drive population health analytics and health equity
White Paper
Mining Unstructured Patient Data For Successful Population Health Management
White Paper
From Data to Evidence: How NLP Advances Population Health and Precision Medicine
Blog
Getting Quality Medicines to Patients Faster in Africa: How to Solve Access Issues
By: Mridu Bhutani
Blog
REMOVING IMMUNIZATION BARRIERS FOR ZERO DOSE CHILDREN: HOW TO MAKE IT WORK?
By: Somto Chloe Keluo-Udeke, Dr. Chijioke Kaduru
Podcast
Cancer Care in Low- and Middle-Income Countries: Bridging the Gap
Blog
Need for a coordinated One Health Approach for the Asian continent
By: Prachitha John
Prev
Next

Explore More

Contact Us